Refractory agitation in the NICU: challenges in prevention, diagnosis, and treatment

Area of Science:

• Neonatal Medicine
• Pediatric Neurology
• Clinical Pharmacology

Background:

• Refractory agitation in neonates presents significant clinical challenges.
• Existing evidence on prevention, diagnosis, and treatment is limited.
• Neonatal intensive care units (NICUs) often encounter agitation unresponsive to standard therapies.

Purpose of the Study:

• To identify the NICU subpopulation at greatest risk for refractory agitation.
• To gain insight into the benefits of alternative medical management on neurodevelopment.
• To propose a practical approach for managing refractory agitation in neonates.

Main Methods:

• Analysis of baseline characteristics and clinical courses of seven NICU patients with refractory agitation.
• Review of standard non-pharmacologic and neurosedative interventions.
• Development of a proposed clinical pathway for risk identification and management.

Main Results:

• Seven cases of refractory agitation in a level IV NICU were identified.
• Patients required escalation beyond standard non-pharmacologic and neurosedative treatments.
• Insights into potential benefits of alternative management on neurodevelopment were gained.

Conclusions:

• A practical approach, including screening and a clinical pathway, is proposed for infants at risk of refractory agitation.
• Developmentally appropriate non-pharmacologic and pharmacologic management strategies are suggested.
• Further research into optimizing neurodevelopmental outcomes for agitated neonates is warranted.